ART Act 2021 safe language — ChatGPT Ads India glossary
ART Act 2021 safe language keeps fertility clinic copy in ChatGPT Ads away from the specific advertising prohibitions India's Assisted Reproductive Technology (Regulation) Act, 2021 places on success-rate claims and outcome framing.
Definition
In plain English: ART Act safe language means a fertility clinic's ChatGPT Ads copy never states or implies a success percentage, never suggests it can help select a child's sex, and never promises a specific outcome — even when a user directly asks for one of those things in conversation.
Technically, the Assisted Reproductive Technology (Regulation) Act, 2021 prohibits ART clinics and banks from advertising success rates, bars any communication suggesting sex-selection capability, and restricts advertising that could mislead patients about outcomes, costs, or accreditation status. The Act treats this as a strict advertising prohibition rather than a disclosure requirement — there is no qualified or footnoted version of a success-rate claim that satisfies it; the figure simply cannot appear in advertising.
Why it matters for Indian healthcare marketers
Fertility is one of the categories where ChatGPT Ads' conversational format creates a compliance trap that static advertising didn't. A search or display ad for an IVF clinic simply doesn't state a success rate if the copywriter knows not to write one. But a ChatGPT Ads conversation is reactive — a prospective patient can ask "what are my chances" or "what's your success rate" directly, and a prompt template optimised to be helpful and conversion-focused will supply an answer unless it's specifically built not to. That single answered question is exactly the advertising the ART Act prohibits, generated not because the advertiser set out to make the claim but because the assistant was trying to be responsive to what the user asked.
This is a materially higher-risk pattern than most other compliance categories in ChatGPT Ads, because the violation is user-triggered rather than advertiser-authored. A fertility clinic can review and approve every line of its opening prompt template, see nothing that violates the ART Act, and still generate a violation the moment a real user asks a natural, predictable follow-up question that the template wasn't built to redirect. Most compliance failures in this category happen exactly this way — not through a bad opening claim, but through an unguarded response to a foreseeable question.
Enforcement under the ART Act sits with the National Assisted Reproductive Technology and Surrogacy Board and state-level authorities, and clinic registration itself is conditioned on compliance — making an advertising violation a registration risk, not just a reputational one, for the clinic operating the campaign.
How ICG uses/measures/handles it in a live engagement
For every fertility or ART client, ICG builds a specific redirect layer into the prompt template that intercepts success-rate, sex-selection, and outcome-probability questions before they reach a generative response — routing the answer to a consultation booking instead of a number, regardless of how the question is phrased. This redirect layer is tested against a list of predictable question variants (percentage, chances, likelihood, comparison-to-other-clinics phrasing) rather than a single expected wording, since real users phrase the same question many different ways.
ICG treats ART Act compliance as a distinct review category from general healthcare compliance overlays, because its prohibitions (no qualified version of a success-rate claim) are stricter than ASCI's substantiation-based approach (a claim can be made if evidenced). Fertility client prompt templates are audited specifically for redirect-layer completeness before launch and re-tested whenever the underlying template is updated.
ICG logs every redirect-triggered conversation for fertility clients as part of the monthly compliance report, giving the client visibility into how often prospective patients ask outcome-probability questions and confirming the redirect layer is functioning as intended across real conversation volume, not just in test drafts.
Related terms
Frequently asked questions
What does the ART Act 2021 restrict in fertility clinic advertising?
The Assisted Reproductive Technology (Regulation) Act, 2021 bars advertisement of success rates by ART clinics and banks, prohibits any communication implying sex-selection capability, and restricts advertising that could mislead a prospective patient about outcomes, cost certainty, or clinic accreditation status.
Why is success-rate advertising specifically barred?
ART outcomes vary enormously by patient age, diagnosis, and protocol, so a single headline success-rate figure was found to mislead prospective patients into overestimating their individual chances — the Act removes the figure from advertising entirely rather than requiring qualification.
How does this affect a ChatGPT Ads conversation about fertility services?
A user asking a fertility-related question directly invites a success-rate answer, and a poorly guarded prompt template will supply one to be helpful — the Act treats that answer as advertising regardless of whether it was volunteered or requested by the user.
How does ICG keep ART Act exposure out of ChatGPT Ads copy?
ICG builds ART-specific redirect language into fertility client prompt templates so any success-rate or outcome-probability question is answered by pointing to a consultation rather than a number, and every draft is checked against the Act's specific prohibitions before launch.
Running ChatGPT Ads for a fertility clinic? Get ART Act-safe copy first.
ICG builds redirect layers that keep your prompt templates outcome-probability free from day one.
